Bruker (BRKR) was downgraded today by JP Morgan (JPM) to neutral from overweight with a price target of $16 due a lack of catalysts to drive the price target higher in the near term. Shares are lower by about three quarters of a percent.
Bruker (BRKR) was downgraded today by JP Morgan (JPM) to neutral from overweight with a price target of $16 due a lack of catalysts to drive the price target higher in the near term. Shares are lower by about three quarters of a percent.